The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.50
Ask: 7.50
Change: 0.25 (3.70%)
Spread: 1.00 (15.385%)
Open: 6.75
High: 7.00
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

27 Mar 2023 07:00

RNS Number : 2333U
Braveheart Investment Group plc
27 March 2023
 

27 March 2023

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Grant of options

 

Braveheart Investment Group (AIM: BRH), announces that, on 24 March 2023, the Company granted options over a total of 2,950,000 ordinary shares of 2p each in the Company ("Ordinary Shares") to the Directors and a service provider to the Company (the "Options"). The Options have been granted pursuant to the Company's share option plan adopted on 16 December 2020. 

 

In order to be eligible to receive new EMI options, Vivian Hallam, Executive Director, has, on 24 March 2023, surrendered 523,808 EMI options previously granted to him on 14 October 2021 and that had an exercise price of 31.5p.

 

In aggregate, 2,900,000 Options have been granted to Directors of the Company, as follows:

 

Name

No. options over Ordinary Shares previously held

No. Options granted

No. options over Ordinary Shares surrendered

Resultant holding of options over Ordinary Shares held

Percentage of the current issued share capital of the Company

Trevor Brown

1,500,000

1,250,000

-

2,750,000

4.3

Vivian Hallam

2,500,000

1,250,000

523,808

3,226,192

5.1

Susan Hagan

50,000

200,000

-

250,000

0.4

Qu Li

0

200,000

-

200,000

0.3

 

The Options granted to Vivian Hallam are EMI options and the Options granted to Trevor Brown, Susan Hagan and Qu Li are unapproved options. The exercise price of the Options is 7.75p, being the closing mid-market price of an Ordinary Share on 24 March 2023, the date of grant. The Options will vest from 27 March 2024 and be exercisable up to 27 March 2033, subject to continued employment. The Options granted to Trevor Brown and Vivian Hallam, as Executive Directors of the Company, have an additional performance related vesting criteria that the closing mid-market price of an Ordinary Share must exceed 9.6875p (being a 25% premium to the Option exercise price) for 10 business days out of a consecutive 30 business day period.

 

Following the grant of the Options and surrender of historic options held by Viv Hallam, the Company now has options outstanding over a total of 7,022,192 Ordinary Shares, equivalent to 11.0% of the Company's current issued share capital.

 

Further details of the Options can be found in the Notification of Dealing Form below.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Trevor Brown

Chief Executive Officer

Vivian Hallam

Executive Director

Susan Hagan

Non-Executive Director

Qu Li

Non-Executive Director

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1a) above 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price: Exercise price of 7.75p per option

 

Trevor Brown

1,250,000

Vivian Hallam

1,250,000

Susan Hagan

200,000

Qu Li

200,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

N/A

 

e)

 

Dates of the transaction

 

24 March 2023

f)

Place of transaction

Outside a trading venue

 

For further information:

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDGGDXXUDDGXL
Date   Source Headline
14th Apr 20117:00 amRNSParticipation in £50m Business Angel Co-Investment
18th Mar 20117:00 amRNSBanking partnership with HSBC
9th Feb 20117:00 amRNSInvestment in Real-Status Limited
4th Feb 20117:00 amRNSInvestment in Pyreos Limited
27th Jan 20117:00 amRNSFurther investment in Design LED Products Ltd
29th Dec 20107:00 amRNSInvestment in payasUgym
17th Dec 20107:00 amRNSInvestment in Chargemaster
10th Dec 20107:00 amRNSInvestment in Tayside Flow Technologies Ltd
30th Nov 20107:00 amRNSHalf Yearly Report
28th Oct 20107:00 amRNSFurther Investment in Biopta Ltd
6th Oct 20107:00 amRNSCompletion of Acquisition
16th Sep 20102:43 pmRNSResult of AGM
6th Sep 20107:00 amRNSFurther Investment in Elonics Ltd
1st Sep 20107:00 amRNSFurther Investment in Traak Systems Ltd
18th Aug 201010:00 amRNSAcquisition
12th Aug 20107:00 amRNSNotice of AGM
26th Jul 20107:00 amRNSFollow-on investment in AppShare
20th Jul 201010:08 amRNSAward of Options
16th Jul 20107:00 amRNSRealisation of Investment
5th Jul 201012:32 pmRNSIssue of Equity
5th Jul 20107:00 amRNSFinal Results
2nd Jul 20107:00 amRNSInvestment in mLED Limited
1st Jul 20107:00 amRNSNotice of Results
19th May 20107:00 amRNSFollow on investment in Conjunct Limited
3rd Mar 20107:00 amRNSInvestment in Tayside Flow Technologies
18th Jan 20107:00 amRNSLaunch of Beta EIS Fund
7th Dec 20097:00 amRNSInterim Results
2nd Dec 20098:54 amRNSSubsidiary Reorganisation
27th Nov 20097:00 amRNSInvesting Policy
28th Sep 20097:00 amRNSEnterprise Finance Guarantee Scheme
25th Sep 20097:00 amRNSFollow on Investment in Appshare
9th Sep 20092:28 pmRNSResult of AGM
10th Aug 20099:14 amRNSNotice of AGM and posting of Annual Report
3rd Jul 20097:00 amRNSAward of Options
1st Jul 20097:00 amRNSFollow-on Investment in NXVision
29th Jun 20097:00 amRNSFollow-on investment in Pyreos
24th Jun 20097:00 amRNSFirst investment for Strathclyde Innovation Fund
18th Jun 20097:00 amRNSFinal Results
16th Jun 20097:00 amRNSNotice of Results
8th Jun 20097:06 amRNSAcquisition
12th May 20097:00 amRNSFollow-on Investment
19th Mar 20097:00 amRNSFollow on Investment in Traak Systems
23rd Feb 20097:00 amRNSInvestment in Pufferfish
20th Jan 20094:39 pmRNSHolding(s) in Company
6th Jan 200910:18 amRNSFollow on Investment
22nd Dec 20087:00 amRNSAward of Options
8th Dec 20087:00 amRNSHalf Yearly Report
4th Dec 20083:39 pmRNSFollow-on Investment
27th Nov 20087:00 amRNSOpening of London Office
12th Nov 20087:00 amRNSSenior Management Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.